| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_268be9afa00cf55b5aa72b1612151ecb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_006eba8be7af0be186ed1deb8e443f14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25dc4dd28c9db257c6a920496cc1ab04 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2017-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5722b7d79ee7fe87467c24146092106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba4453defc1fdefa10e0d5b39e9ee4cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6f3abb57887d136f487ab7c44b3ae05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a001147e5843b203e823693e0191c179
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae59970f619dc085c242416d7e1ae92d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ec229b13309e232f13c9ca36dbb1744 |
| publicationDate |
2018-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2018101434-A1 |
| titleOfInvention |
Glycosylated chlorin e6 derivative or a pharmaceutically acceptable salt thereof, pharmaceutical composition, method for destroying target, and method for producing glycosylated chlorin e6 derivative or a pharmaceutically acceptable salt thereof |
| abstract |
The present invention addresses the problem of providing a glycosylated chlorin e6 derivative which has excellent tumor cell-killing properties (phototoxic property) and growth-inhibiting effect on tumor tissues and which is used for photodynamic therapy. The glycosylated chlorin e6 derivative according to the present invention is applicable for use in photodynamic diagnosis as well. The present invention pertains to a glycosylated chlorin e6 derivative represented by general formula (1) or a pharmaceutically acceptable salt thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023048233-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113461697-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113461697-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11787816-B2 |
| priorityDate |
2016-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |